Major business players operating in the drug discovery services market include:
Charles River Laboratories International, Inc.
Thermo Fisher Scientific, Inc.
Wuxi AppTec
Eurofins Scientific
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
In 2022, the global market for drug discovery services was valued at USD 16.3 billion and will grow at 14.1% CAGR from 2023 to 2032, driven by rising R&D investments by private players and the government on novel drug discovery and development.
The small-molecule drugs segment will grow at a 14.4% CAGR from 2023 to 2032, owing to the oral bioavailability and favorable pharmacokinetic properties of small molecule drugs.
North America market held over 43.8% of the revenue share in 2022, attributed to the growing prevalence of chronic diseases coupled with rising demand for novel drugs in the region.
Notable players in the drug discovery services industry include Thermo Fisher Scientific, Inc., Eurofins Scientific, EVOTEC, Syngene International Limited, Wuxi AppTec, Laboratory Corporation of American Holdings, and Curia Global, Inc., among others.